Effects of the combination of a monoclonal agonistic mouse anti-OX40 antibody and toll-like receptor agonists: Unmethylated CpG and LPS on an MB49 bladder cancer cell line in a mouse model.

Gulyás, Dominik; Kovács, Gábor; Jankovics, István; Mészáros, László; Lorincz, Márta; Dénes, Béla

Gulyás, Dominik; Kovács, Gábor; Jankovics, István; Mészáros, László; Lorincz, Márta; Dénes, Béla.

Afiliação

Gulyás D; Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary.
Kovács G; Department of Urology, Medical Centre, Hungarian Defence Forces, Budapest, Hungary.
Jankovics I; Microbiology Department, CMC Southern Clinic, Budapest, Hungary.
Mészáros L; Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary.
Lorincz M; Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary.
Dénes B; Veterinary Diagnostic Directorate, National Food Chain Safety Office, Budapest, Hungary.

PLoS One ; 17(7): e0270802, 2022.

Article em En | MEDLINE | ID: mdl-35802726

Assuntos

Lipopolissacarídeos; Neoplasias da Bexiga Urinária; Animais; Anticorpos; Linhagem Celular; Modelos Animais de Doenças; Imunoterapia; Lipopolissacarídeos/farmacologia; Camundongos; Receptores OX40; Receptor Toll-Like 9; Neoplasias da Bexiga Urinária/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Lipopolissacarídeos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google